Mumbai, August 2023: Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced that a delegation of senior members of the U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) together with local government officials recently visited the Company's manufacturing facility in Matoda, India. The visit followed the G20 Health Ministers' meeting in Gandhinagar, India on August 18 and 19, where health ministers from around the world met to discuss global health issues.